CLAY B. SIEGALL - President and CEO, Director at Immunome Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
IMNM on Nasdaq
All Insider Reports
All Insider Reports

CLAY B. SIEGALL - trading volume in the past year for Immunome Inc.

Holdings reported by CLAY B. SIEGALL for Immunome Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 665,254 $14,070,122 $21.15 30 Dec 2025 Direct
Employee Stock Option (right to buy) 800,000 29 Jul 2025 Direct Common Stock

Transactions reported by CLAY B. SIEGALL for Immunome Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.